ATAI
AtaiBeckleyยทNASDAQ
--
--(--)
--
--(--)
ATAI Profile
Ataibeckley Inc.
A clinical-stage biopharmaceutical company that developing treatment for mental health disorders
c/o atai Life Sciences US, Inc., c/o Industrious NYC, 250 West 34th Street, New York, NY 10119
--
AtaiBeckley Inc., was incorporated under the laws of the Netherlands on September 10, 2020. On January 11, 2021, it was renamed ATAI Life Sciences B.V. On November 5, 2025, it was renamed Atai Beckley N.V. On January 2, 2026, the company name was changed to AtaiBeckley Inc., and it was transformed into a company incorporated under the laws of the State of Delaware. AtaiBeckley Inc., a clinical-stage biopharmaceutical company, develops highly effective mental health therapies to improve patient outcomes. The company is advancing the development of a range of product candidates designed to address the complexity of mental health disorders.
